Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma (Annals of Hematology, (2018), 10.1007/s00277-018-3418-2)

Dai Maruyama, Kunihiro Tsukasaki, Toshiki Uchida, Yoshinobu Maeda, Hirohiko Shibayama, Hirokazu Nagai, Mitsutoshi Kurosawa, Yoko Suehiro, Kiyohiko Hatake, Kiyoshi Ando, Isao Yoshida, Michihiro Hidaka, Tohru Murayama, Yoko Okitsu, Norifumi Tsukamoto, Masafumi Taniwaki, Junji Suzumiya, Kazuo Tamura, Takahiro Yamauchi, Ryuzo UedaKensei Tobinai

Research output: Contribution to journalArticle

Abstract

The original version of this article contained a mistake in Fig. 4. The horizontal axis should be 36 instead of 60.

Original languageEnglish
JournalAnnals of Hematology
DOIs
Publication statusAccepted/In press - Jan 1 2018

    Fingerprint

ASJC Scopus subject areas

  • Hematology

Cite this

Maruyama, D., Tsukasaki, K., Uchida, T., Maeda, Y., Shibayama, H., Nagai, H., Kurosawa, M., Suehiro, Y., Hatake, K., Ando, K., Yoshida, I., Hidaka, M., Murayama, T., Okitsu, Y., Tsukamoto, N., Taniwaki, M., Suzumiya, J., Tamura, K., Yamauchi, T., ... Tobinai, K. (Accepted/In press). Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma (Annals of Hematology, (2018), 10.1007/s00277-018-3418-2). Annals of Hematology. https://doi.org/10.1007/s00277-018-3455-x